Phase I–II clinical trial with alpha-difluoromethylornithine—An inhibitor of polyamine biosynthesis
- 1 August 1987
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 23 (8) , 1103-1107
- https://doi.org/10.1016/0277-5379(87)90141-6
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Phase I evaluation of intravenous difluoromethylornithine — a polyamine inhibitorInvestigational New Drugs, 1985
- Phase I trial and pharmacokinetic studies of alpha-difluoromethylornithine--an inhibitor of polyamine biosynthesis.Journal of Clinical Oncology, 1984
- Tumor Suppression with a Combination of α-Difluoromethyl Ornithine and InterferonScience, 1983
- Polyamine metabolism and functionAmerican Journal of Physiology-Cell Physiology, 1982
- Ornithine Decarboxylase: Essential in Proliferation But Not Differentiation of Human Promyelocytic Leukemia CellsScience, 1982
- Selective killing of transformed cells in combination with inhibitors of polyamine biosynthesis and S-phase specific drugsCell Biology International Reports, 1981
- Role of Polyamines in the Control of Cell Proliferation and DifferentiationDifferentiation, 1981
- Inhibition of polyamine biosynthesis by α-difluoromethyl ornithine potentiates the cytotoxic effects of arabinosyl cytosine in HeLa cellsBiochemical and Biophysical Research Communications, 1980
- Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogsJournal of the American Chemical Society, 1978
- POLYAMINES AS MARKERS OF RESPONSE AND DISEASE ACTIVITY IN CANCER CHEMOTHERAPY1977